Xiaoyun Hu

发表

Longitudinal Change of Body Mass Index Is Associated With Alanine Aminotransferase Elevation After Complete Viral Suppression in Chronic Hepatitis B Patients.

Jian Sun, Xieer Liang, J. Hou, 2019, The Journal of infectious diseases.

Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts

Guanting Lu, Xiaoxiang Rong, W. Fan, 2022, Frontiers in Immunology.

Multiple Antigen Stimulating Cellular Therapy (MASCT) For Hepatocellular Carcinoma After Curative Treatment: A Retrospective Study

J. Hou, Jinzhang Chen, Ya-bing Guo, 2018, Journal of Cancer.

DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway

Jinzhang Chen, Xiaoyun Hu, G. Yuan, 2020, Annals of medicine.

Development and validation of a model for hepatitis B e antigen seroconversion in entecavir‐treated patients with chronic hepatitis B

A. Boonstra, Jian Sun, Xieer Liang, 2019, Journal of medical virology.

Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxis

Jinzhang Chen, Xiaoyun Hu, Rong Li, 2022, BMC Infectious Diseases.

OTT_A_286169 12683..12693

Jinzhang Chen, Ya-bing Guo, Xiaoyun Hu, 2020 .

Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway.

Li Liu, Dehua Wu, Xiaoyun Hu, 2016, Journal of pharmacological sciences.

Effectiveness and safety of toripalimab, camrelizumab, and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients

W. Huang, Jinzhang Chen, Ya-bing Guo, 2020, Annals of translational medicine.

Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study

M. Chen, Jinzhang Chen, Ya-bing Guo, 2022, Frontiers in Oncology.

Interaction between hepatitis B virus infection and the efficacy of camrelizumab in combination with apatinib therapy in patients with hepatocellular carcinoma: a multicenter retrospective cohort study

W. Huang, W. Fan, Jinzhang Chen, 2021, Annals of translational medicine.

Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients

W. Huang, Qifan Zhang, Jinzhang Chen, 2021, Frontiers in Immunology.

Next-Generation Sequencing Characterizes the Landscape of Somatic Mutations and Pathways in Metastatic Bile Tract Carcinoma

Qifan Zhang, Jinzhang Chen, Xiaoyun Hu, 2020, Journal of oncology.

5‐Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)‐mediated apoptosis in hepatocellular carcinoma

Xiaoyun Hu, Li Liu, Jiyun Liang, 2015, Clinical and experimental pharmacology & physiology.

Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

W. Huang, W. Fan, Jinzhang Chen, 2020, OncoTargets and therapy.

Gastrointestinal 5-fluorouracil combined with apigenin enhances anticancer activity through ΔΨ m-mediated apoptosis in hepatocellular carcinoma

Xiaoyun Hu, Li Liu, Jiyun Liang, 2014 .

Transarterial chemoembolization with/without immune checkpoint inhibitors plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a single center, propensity score matching real-world study

Jinzhang Chen, Xiaoyun Hu, Rong Li, 2024, Discover. Oncology.

Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study.

Jinzhang Chen, Xiaoyun Hu, Rong Li, 2023, International immunopharmacology.